Feed / CRSP

CRISPR Therapeutics AG

CRSP

Healthcare · 57.43 -1.2% today

Partial group confirmationMarket checked 24 Aug, 15:30 GMT-4

Jodie situation report

CRISPR Therapeutics AG's move is being confirmed by its market group.

CRSP accounts for 21.8% of the group's measured movement across 6.5 effective names. raw member direction is mixed; 8 of 10 session-normalized paths align to the downside. Capital-flow agreement is 53%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveAligned contributor#2 of 10 by movement share
Group movement share21.8%Absolute path energy—not portfolio weight
Relative path-3.81%aligned
Effective breadth6.5 / 10broad
Relative alignment8/10downside path · 2 counter-moving
Capital-flow agreement53%not yet clean
SEQUENCE READ

CORT, CAI, MRNA moved materially before CRSP. CRSP crossed its material path threshold at 10:10 ET, 3985 minutes after the first measured mover. GH, NTRA, VCYT followed.

EVIDENCE COVERAGE

5 of 10 members in Cancer Diagnostics are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 7 of 10 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as MYGN begins moving with the group.

Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.

Watch this read

Who this business touches

The relationships behind CRSP

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

VERXVertex, Inc.partnerMay 4, 2026 ▾

“CASGEVY is the first therapy to emerge from our strategic partnership with Vertex and is being advanced under a joint development and commercialization agreement between us and Vertex and certain of its affiliates.”

SIRISirius XM Holdings Inc.partnerMay 4, 2026 ▾

“We are also pursuing additional delivery technologies, including LNPs, for delivery to tissues beyond the liver, including hematopoietic stem cells and T cells.”

Depended on by

VRTXVertex Pharmaceuticals IncorporatedpartnerMay 5, 2026 ▾

“Over the last several years, we entered into collaboration agreements with a number of companies, including CRISPR T herapeutics AG (“CRISPR”) and Entrada Therapeutics, Inc.”

Filing peers

EDITSANA

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 28 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CRSP is currently a Participant in the organic co-movement group Cancer Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.